Human papilloma virus (HPV) infection often only forms asymptomatic or benign papillomas, but in some types, it causes malignant tumors. Among cases of laryngeal tumor, HPV is detected in more than 90% of laryngeal papillomas and is related to the onset. In our department, HPV infection was found in 95% of cases, all of which were low-risk type (types 6 and 11). Laryngeal papillomas are typically treated by surgery, but in cases of multiple relapse, a cure can be difficult to achieve with surgical treatment alone. Given that HPV infection is a viral disease, it is important for surgical treatment to reduce the tumor volume, disease extent, and viral load as well as to prevent as much normal tissue as possible from being injured. Adjuvant therapy after surgery is important for the prevention of recurrence, but effective adjuvant therapy is not yet available for all cases, so the development of a suitable adjuvant therapy is necessary. Since HPV is related to the onset of head and neck cancer, especially oropharyngeal cancer, the prognosis differs depending on the presence or absence of HPV infection. In the case of oropharyngeal carcinoma, the 2018 version of the head and neck clinical practice guidelines was revised to include staging with or without HPV infection. The involvement of HPV in laryngeal cancer also needs to be considered. Laryngeal cancer patients had HPV infection in 18% of cases, with type 16 viruses accounting for 81% of these cases. HPV-related laryngeal carcinoma, which seems to be actually involved in carcinogenesis, is relatively infrequent (2.3% of cases). In laryngeal cancer, the possibility of HPV alone being an oncogenic factor is low, suggesting that this is a tumor involving multiple factors, such as smoking and drinking.
View full abstract